Response to: Correspondence on "Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis" by Pantelidis et al

Affiliations

¹ Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
² Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
³ Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands s.m.boekholdt@amsterdamumc.nl.

Comment

Yannick Kaiser et al. Heart. 2022 Apr.

. 2022 Apr;108(7):576-577.

doi: 10.1136/heartjnl-2021-320644. Epub 2022 Jan 27.

¹ Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
² Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
³ Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands s.m.boekholdt@amsterdamumc.nl.

No abstract available

Keywords: aortic valve stenosis.

Conflict of interest statement

Competing interests: None declared.

Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis.
Kaiser Y, Nurmohamed NS, Kroon J, Verberne HJ, Tzolos E, Dweck MR, Somsen AG, Arsenault BJ, Stroes ESG, Zheng KH, Boekholdt SM. Kaiser Y, et al. Heart. 2022 Jan;108(1):61-66. doi: 10.1136/heartjnl-2021-319804. Epub 2021 Sep 30. Heart. 2022. PMID: 34593533 Free PMC article.
Correspondence on "Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis" by Kaiser et al.
Pantelidis P, Oikonomou E. Pantelidis P, et al. Heart. 2022 Apr;108(7):575-576. doi: 10.1136/heartjnl-2021-320643. Epub 2022 Jan 27. Heart. 2022. PMID: 35086886 No abstract available.